Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase☆
References (28)
- et al.
Administration of a peripheral decarboxylase inhibitor with L-dopa to depressed patients
Lancet
(1970) - et al.
Observations on the effect of levodopa on tardive, lingual-facial-buccal dyskinesia
J. neurol. Sci.
(1971) - et al.
Inhibition of dopa decarboxylase by hydrazine analogue of methyldopa
Biochem. Pharmacol.
(1962) - et al.
Analytical method for measuring dopa and some metabolites in urine and plasma of Parkinsonian patients
Clin. chim. Acta
(1971) - et al.
Effects of L-3,4-dihydroxyphenylalanine on spinal reflex activity
J. Pharmacol. exp. Ther.
(1970) - et al.
Uptake of catecholamines into serotoninergic nerve cells as demonstrated by fluorescence histochemistry
Experientia (Basel)
(1971) - et al.
Increase in cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase
Nature (Lond.)
(1967) - et al.
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa
Brit. med. J.
(1971) Biochemical aspects of abnormal movements induced by L-dopa
- et al.
Effects of L-dopa on norepinephrine metabolism in the brain
Attenuation of the vomiting response to L-dopa after decarboxylase inhibition
Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain
Experientia (Basel)
(1968)
Modification of Parkinsonism: Chronic treatment with L-dopa
New. Engl. J. Med.
(1969)
Plasma dopa response to levodopa administration in man: Effects of a peripheral decarboxylase inhibitor
Clin. Pharmacol. exp. Ther.
(1971)
Cited by (20)
Quantification of l-3-(3-hydroxy-4-pivaloyloxyphenyl) alanine (NB-355) by high-performance liquid chromatography using o-phthalaldehyde/N-acetyl-l-cysteine derivatization
1989, Journal of Chromatography B: Biomedical Sciences and ApplicationsHigh-performance liquid chromatography with amperometric detection of plasma L-3,4-dihydroxyphenylalanine in parkinsonian patients
1983, Journal of Chromatography B: Biomedical Sciences and ApplicationsL|-DOPA Effect on Blood Pressure in Man
1977, Progress in Brain ResearchCatechol-O-methyltransferase inhibitors in the treatment of Parkinson’s disease
2012, Parkinson's Disease, Second EditionMucuna pruriens in Parkinson's disease: A double blind clinical and pharmacological study
2004, Journal of Neurology, Neurosurgery and PsychiatryCatechol-O-Methyltransferase Inhibitors in the Treatment of Parkinson’s Disease
2004, Parkinson's Disease
- ☆
This work was supported by the Wellcome Trust and the Medical Research Council.
Copyright © 1972 Published by Elsevier B.V.